Anti-CXCL9 antibody [EPR23999-5]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CXCL9 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human samples.
View Alternative Names
CMK, MIG, SCYB9, CXCL9, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9, HuMIG
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CXCL9 antibody [EPR23999-5] (AB263442)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized THP-1 (human monocytic leukemia monocyte) treated with 100ng/ml IFN-gamma and 1ug/ml LPS (Lipopolysaccharide) for 48 hours (Red)/ Untreated control (Green) cells labelling CXCL9 with ab263442 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) isotype control (Black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue).
A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-CXCL9 antibody [EPR23999-5] (AB263442)
CXCL9 was immunoprecipitated from 0.35 mg THP-1(human monocytic leukemia monocyte) (treated with 100ng/ml IFN-γ and 1ug/ml LPS (Lipopolysaccharide) for 48 hours) whole cell lysate with ab263442 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab263442 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : THP-1 treated with 100ng/ml IFN-γ and 1ug/ml LPS (Lipopolysaccharide) for 48 hours, whole cell lysate 10 ug
Lane 2 : ab263442 IP in THP-1 treated with 100ng/ml IFN-γ and 1ug/ml LPS(Lipopolysaccharide) for 48 hours whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab263442 in THP-1 treated with 100ng/ml IFN-γ and 1ug/ml LPS(Lipopolysaccharide) for 48 hours whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-CXCL9 antibody [EPR23999-5] (ab263442)
Predicted band size: 14 kDa
Observed band size: 13 kDa,14 kDa
false
- WB
Lab
Western blot - Anti-CXCL9 antibody [EPR23999-5] (AB263442)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile is consistent with what has been described in the literature (PMID : 15154616, 22973274).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CXCL9 antibody [EPR23999-5] (ab263442) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia monocyte), whole cell lysate at 20 µg
Lane 2:
THP-1 (treated with 200 ng /ml IFN-gamma and 50 ng/ml LPS (Lipopolysaccharide) for 24 hours), whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 14 kDa
Observed band size: 13 kDa,14 kDa
false
- WB
Lab
Western blot - Anti-CXCL9 antibody [EPR23999-5] (AB263442)
False colour image of Western blot : Anti-CXCL9 antibody [EPR23999-5] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab263442 was shown to bind specifically to CXCL9. A band was observed at 17 kDa in treated wild-type THP-1 cell lysates with no signal observed at this size in CXCL9 knockout cell line ab282347 (knockout cell lysate ab283019). To generate this image, wild-type and CXCL9 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-CXCL9 antibody [EPR23999-5] (ab263442) at 1/1000 dilution
Lane 1:
Wild-type THP-1 untreated control cell lysate at 20 µg
Lane 2:
Wild-type THP-1 treated IFNg (200 ng/mL, 24 h) + LPS (50 ng/mL, 24 h) cell lysate at 20 µg
Lane 3:
CXCL9 knockout THP-1 untreated control cell lysate at 20 µg
Lane 4:
CXCL9 knockout THP-1 treated IFNg (200 ng/mL, 24 h) + LPS (50 ng/mL, 24 h) cell lysate at 20 µg
Observed band size: 17 kDa
false
- WB
Lab
Western blot - Anti-CXCL9 antibody [EPR23999-5] (AB263442)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile is consistent with what has been described in the literature (PMID : 15154616, 22973274).
Exposure time : 5.5 seconds.
All lanes:
Western blot - Anti-CXCL9 antibody [EPR23999-5] (ab263442) at 1/1000 dilution
All lanes:
His-tagged human purified recombinant full-length protein CXCL9, 10 ng
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 14 kDa
Observed band size: 13 kDa,14 kDa
false
Related conjugates and formulations (1)
-
Anti-CXCL9 antibody [EPR23999-5] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This cytokine plays a pivotal role in the immune system by regulating leukocyte trafficking. CXCL9 exerts its function through binding to the CXCR3 receptor attracting T cells towards sites of inflammation or infection. This interaction is significant in mediating immune surveillance and host defense. CXCL9 does not form part of a larger protein complex but its chemokine activity is critical for immune system coordination. Scientific studies often highlight its involvement through CXCL9 function and expression analysis.
Pathways
CXCL9 significantly influences the chemokine signaling pathway and the Th1-type adaptive immune response. Within these pathways it interacts closely with other chemokines like CXCL10 and CXCL11 which also bind to the CXCR3 receptor. These pathways highlight the coordinated mobilization of T cells during immune challenges and inflammation emphasizing how CXCL9 is often examined alongside these related chemokines in research settings.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com